• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

孕激素受体的较低 Allred 评分与乳腺癌 21 基因检测的较高复发评分强烈相关。

A lower Allred score for progesterone receptor is strongly associated with a higher recurrence score of 21-gene assay in breast cancer.

机构信息

Department of Pathology, University of Rochester of Rochester Medical Center, New York, USA.

出版信息

Cancer Invest. 2010 Nov;28(9):978-82. doi: 10.3109/07357907.2010.496754.

DOI:10.3109/07357907.2010.496754
PMID:20690804
Abstract

Among the 77 infiltrating breast carcinomas, we found that progesterone receptor (PR) expression was inversely associated with recurrence score (RS, p < .0001). RS is also significantly associated with tubule formation, mitosis, and luminal B subtype. The equation of RS = 17.489 + 2.071 (tubal formation) + 2.926 (mitosis) -2.408 (PR) -1.061 (HER2) + 7.051 (luminal A) + 29.172 (luminal B) predicts RS with an R² of 0.65. In conclusion, PR negativity, luminal B subtype, tubal formation, and mitosis are strongly correlated with a higher RS.

摘要

在 77 例浸润性乳腺癌中,我们发现孕激素受体(PR)表达与复发评分(RS)呈负相关(p<0.0001)。RS 还与管腔形成、有丝分裂和腔 B 型显著相关。RS 的方程为 RS=17.489+2.071(管腔形成)+2.926(有丝分裂)-2.408(PR)-1.061(HER2)+7.051(腔 A)+29.172(腔 B),其预测 RS 的 R²为 0.65。总之,PR 阴性、腔 B 型、管腔形成和有丝分裂与较高的 RS 密切相关。

相似文献

1
A lower Allred score for progesterone receptor is strongly associated with a higher recurrence score of 21-gene assay in breast cancer.孕激素受体的较低 Allred 评分与乳腺癌 21 基因检测的较高复发评分强烈相关。
Cancer Invest. 2010 Nov;28(9):978-82. doi: 10.3109/07357907.2010.496754.
2
FOXA1 expression in breast cancer--correlation with luminal subtype A and survival.乳腺癌中FOXA1的表达——与腔面A型及生存的相关性
Clin Cancer Res. 2007 Aug 1;13(15 Pt 1):4415-21. doi: 10.1158/1078-0432.CCR-07-0122.
3
Breast cancer subtype approximated by estrogen receptor, progesterone receptor, and HER-2 is associated with local and distant recurrence after breast-conserving therapy.通过雌激素受体、孕激素受体和人表皮生长因子受体2来近似划分的乳腺癌亚型与保乳治疗后的局部和远处复发相关。
J Clin Oncol. 2008 May 10;26(14):2373-8. doi: 10.1200/JCO.2007.14.4287. Epub 2008 Apr 14.
4
[Clinical characteristics and survival in the operable breast cancer patients with different molecular subtypes].[不同分子亚型可手术乳腺癌患者的临床特征与生存情况]
Zhonghua Zhong Liu Za Zhi. 2009 Jun;31(6):447-51.
5
Tumor gene expression and prognosis in breast cancer patients with 10 or more positive lymph nodes.伴有10个或更多阳性淋巴结的乳腺癌患者的肿瘤基因表达与预后
Clin Cancer Res. 2005 Dec 15;11(24 Pt 1):8623-31. doi: 10.1158/1078-0432.CCR-05-0735.
6
The oncotype DX recurrence score is correlated with a composite index including routinely reported pathobiologic features.Oncotype DX 复发评分与包括常规报告的病理生物学特征的综合指数相关。
Cancer Invest. 2010 Nov;28(9):969-77. doi: 10.3109/07357907.2010.512600.
7
Prediction of local recurrence, distant metastases, and death after breast-conserving therapy in early-stage invasive breast cancer using a five-biomarker panel.使用五生物标志物组合预测早期浸润性乳腺癌保乳治疗后的局部复发、远处转移和死亡情况。
J Clin Oncol. 2009 Oct 1;27(28):4701-8. doi: 10.1200/JCO.2008.21.7075. Epub 2009 Aug 31.
8
Association between standard clinical and pathologic characteristics and the 21-gene recurrence score in breast cancer patients: a population-based study.乳腺癌患者的标准临床和病理特征与21基因复发评分之间的关联:一项基于人群的研究。
Cancer. 2008 Feb 15;112(4):731-6. doi: 10.1002/cncr.23225.
9
Characterization of breast cancer subtypes by quantitative assessment of biological parameters: relationship with clinicopathological characteristics, biological features and prognosis.通过生物参数的定量评估对乳腺癌亚型进行特征分析:与临床病理特征、生物学特性及预后的关系
Eur J Obstet Gynecol Reprod Biol. 2008 Dec;141(2):147-52. doi: 10.1016/j.ejogrb.2008.07.021. Epub 2008 Sep 2.
10
Morphological profile and association of HER-2/neu with prognostic markers in breast carcinoma in Northern Pakistan.巴基斯坦北部乳腺癌的形态学特征及HER-2/neu与预后标志物的关联
J Coll Physicians Surg Pak. 2009 Feb;19(2):99-103.

引用本文的文献

1
LINC00887 promotes GCN5-dependent H3K27cr level and CRC metastasis via recruitment of YEATS2 and enhancing ETS1 expression.LINC00887 通过募集 YEATS2 和增强 ETS1 表达促进 GCN5 依赖性 H3K27cr 水平和 CRC 转移。
Cell Death Dis. 2024 Sep 30;15(9):711. doi: 10.1038/s41419-024-07091-w.
2
Epidemiology of early vs late recurrence among women with early stage estrogen receptor-positive breast cancer in the Pathways Study.Pathways 研究中早期激素受体阳性乳腺癌女性中早期与晚期复发的流行病学。
J Natl Cancer Inst. 2024 Oct 1;116(10):1621-1631. doi: 10.1093/jnci/djae128.
3
Progesterone Receptor Expression Level Predicts Prognosis of Estrogen Receptor-Positive/HER2-Negative Young Breast Cancer: A Single-Center Prospective Cohort Study.
孕激素受体表达水平预测雌激素受体阳性/人表皮生长因子受体2阴性年轻乳腺癌患者的预后:一项单中心前瞻性队列研究
Cancers (Basel). 2023 Jun 30;15(13):3435. doi: 10.3390/cancers15133435.
4
Prognoses of Patients with Hormone Receptor-Positive and Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer Receiving Neoadjuvant Chemotherapy before Surgery: A Retrospective Analysis.术前接受新辅助化疗的激素受体阳性且人表皮生长因子受体2阴性乳腺癌患者的预后:一项回顾性分析。
Cancers (Basel). 2023 Feb 10;15(4):1157. doi: 10.3390/cancers15041157.
5
The Rochester Modified Magee Algorithm (RoMMa): An Outcomes Based Strategy for Clinical Risk-Assessment and Risk-Stratification in ER Positive, HER2 Negative Breast Cancer Patients Being Considered for Oncotype DX Testing.罗切斯特改良马吉算法(RoMMa):一种针对考虑进行Oncotype DX检测的雌激素受体阳性、人表皮生长因子受体2阴性乳腺癌患者进行临床风险评估和风险分层的基于结果的策略。
Cancers (Basel). 2023 Jan 31;15(3):903. doi: 10.3390/cancers15030903.
6
Deep Learning-Based Pathology Image Analysis Enhances Magee Feature Correlation With Oncotype DX Breast Recurrence Score.基于深度学习的病理学图像分析增强了马吉特征与Oncotype DX乳腺癌复发评分的相关性。
Front Med (Lausanne). 2022 Jun 14;9:886763. doi: 10.3389/fmed.2022.886763. eCollection 2022.
7
Prognostic Relevance of Progesterone Receptor Levels in Early Luminal-Like HER2 Negative Breast Cancer Subtypes: A Retrospective Analysis.早期腔面样HER2阴性乳腺癌亚型中孕激素受体水平的预后相关性:一项回顾性分析
Front Oncol. 2022 Mar 28;12:813462. doi: 10.3389/fonc.2022.813462. eCollection 2022.
8
A nomogram for predicting probability of low risk of MammaPrint results in women with clinically high-risk breast cancer.用于预测临床高风险乳腺癌女性中 MammaPrint 检测低风险概率的列线图。
Sci Rep. 2021 Dec 6;11(1):23509. doi: 10.1038/s41598-021-02992-8.
9
Mammography-based radiomics for predicting the risk of breast cancer recurrence: a multicenter study.基于乳腺 X 线摄影的放射组学预测乳腺癌复发风险:一项多中心研究。
Br J Radiol. 2021 Nov 1;94(1127):20210348. doi: 10.1259/bjr.20210348. Epub 2021 Sep 14.
10
Predictability of 21-Gene Recurrence Score Assay by Using Pathological and Immunohistochemical Parameters in Breast Cancer.利用病理和免疫组化参数预测乳腺癌21基因复发评分检测结果
Breast Cancer (Auckl). 2020 Dec 8;14:1178223420977848. doi: 10.1177/1178223420977848. eCollection 2020.